Steve Valiquette
Stock Analyst
(2.37)
# 1,657
Out of 4,648 analysts
177
Total ratings
46.55%
Success rate
-3.43%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.87 | +35.29% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $9.33 | -14.26% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $525.94 | +17.12% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $5.87 | +53.32% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.89 | +28.53% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.63 | +115.98% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $17.23 | +39.33% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $54.65 | +57.37% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $63.82 | +33.19% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $363.15 | -17.39% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $95.39 | -7.75% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $37.74 | -9.91% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $162.48 | -35.38% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $64.33 | -14.50% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.68 | -30.41% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $208.80 | -31.99% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $25.17 | -80.14% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $100.22 | -43.13% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $134.32 | -38.95% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $21.98 | -18.11% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $40.01 | -22.52% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $330.93 | +13.32% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $31.06 | -38.83% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $6.24 | +12.18% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $255.55 | +123.05% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $29 | $14.28 | +103.08% | 2 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $111.90 | -42.81% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $312.60 | -0.83% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $557.90 | +1.27% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $9.06 | +2,549.01% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $12.65 | +492.89% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $5.90 | +222.03% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $4.40 | +127.53% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $20.01 | +69.92% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $4.51 | +343.46% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $182.63 | +42.36% | 1 | Feb 19, 2021 |
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.87
Upside: +35.29%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $9.33
Upside: -14.26%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $525.94
Upside: +17.12%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $5.87
Upside: +53.32%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.89
Upside: +28.53%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.63
Upside: +115.98%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $17.23
Upside: +39.33%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $54.65
Upside: +57.37%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $63.82
Upside: +33.19%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $363.15
Upside: -17.39%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $95.39
Upside: -7.75%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $37.74
Upside: -9.91%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $162.48
Upside: -35.38%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $64.33
Upside: -14.50%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.68
Upside: -30.41%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $208.80
Upside: -31.99%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $25.17
Upside: -80.14%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $100.22
Upside: -43.13%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $134.32
Upside: -38.95%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $21.98
Upside: -18.11%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $40.01
Upside: -22.52%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $330.93
Upside: +13.32%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $31.06
Upside: -38.83%
Oct 21, 2022
Maintains: Overweight
Price Target: $8 → $7
Current: $6.24
Upside: +12.18%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $255.55
Upside: +123.05%
Jun 29, 2022
Reinstates: Overweight
Price Target: $29
Current: $14.28
Upside: +103.08%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $111.90
Upside: -42.81%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $312.60
Upside: -0.83%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $557.90
Upside: +1.27%
Nov 11, 2021
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $9.06
Upside: +2,549.01%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $12.65
Upside: +492.89%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $5.90
Upside: +222.03%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $4.40
Upside: +127.53%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $20.01
Upside: +69.92%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $4.51
Upside: +343.46%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $182.63
Upside: +42.36%